Psyllium Husk for High Cholesterol (Dyslipidemia)

The best-replicated finding is simple. In a 2018 meta-analysis of 28 randomised trials (1,924 people), a median of about 10.2 g of psyllium a day lowered LDL cholesterol by 0.33 mmol/L (95% CI 0.27 to 0.38), non-HDL cholesterol by 0.39 mmol/L and apolipoprotein B by 0.05 g/L. A 2024 analysis of 29 trials found nearly the same LDL fall, 0.35 mmol/L, and an estimated 7% lower cardiovascular event risk. That risk figure is a projection from cholesterol levels, not a measured result.

Newer data temper the picture. A 2025 meta-analysis of 41 trials found an average LDL fall of 8.55 mg/dL (about 0.22 mmol/L), with high heterogeneity (I2 about 88%) and no clear effect on HDL or triglycerides. In practice that is a fall of around 5 to 10% on top of diet: useful, but not a substitute for a statin when LDL is far above target.

The most direct human evidence is a randomised, double-blind crossover study of 20 men with moderate hypercholesterolaemia (LDL about 184 mg/dL). They took 15 g a day of psyllium or a cellulose placebo for 40 days each. LDL cholesterol averaged 169 mg/dL on psyllium versus 179 on placebo. Bile acid turnover rose, and bile acid synthesis increased in the men whose LDL fell by more than 10%. The authors concluded that psyllium lowers LDL primarily by stimulating bile acid synthesis.

In plain terms, the gel-forming fibre keeps more bile acids moving through the gut, so the liver pulls cholesterol from the blood to make replacements. Relative cholesterol absorption also dipped slightly (45% on psyllium versus 49% on placebo), but absolute absorption did not change.

That study was small, in men only, and used 15 g a day, more than the typical dose. It explains why LDL falls but not how far it will fall in a given person, and lowering LDL is a surrogate for heart protection, not proof of it.

Other lipid effects are less consistent. In 28 men with cardiovascular disease and already low LDL, 10.5 g of husk a day for 8 weeks lowered triglycerides 6.7% and raised HDL cholesterol 6.7% compared with insoluble seeds, but the abstract reports no LDL change versus baseline. Do not read these as a general HDL or triglyceride benefit: the larger meta-analyses found none.

Pooled analyses cluster around 10 g of psyllium a day: the 2018 meta-analysis used a median of about 10.2 g, and the 2000 analysis pooled eight trials of exactly 10.2 g a day for at least 8 weeks. Individual trials ranged from 3 to 20.4 g. One placebo-controlled trial used 5.1 g twice a day for 8 weeks and cut LDL by 6.4% to 7.2%.

Whether more is better is unsettled. A 2009 meta-analysis of 21 trials found a significant dose-response and a growing effect with treatment time. The 2025 analysis, with higher heterogeneity, found no significant linear effect of dose or duration. The US FDA health claim is stated differently again: 7 g or more a day of soluble fibre from psyllium seed husk, as part of a diet low in saturated fat and cholesterol, worded as a diet that may reduce heart disease risk. Check labels, because grams of product and grams of soluble fibre are not the same thing.

Five meta-analyses point the same way. The 2018 analysis (28 trials, 1,924 people) found LDL down 0.33 mmol/L; its LDL and non-HDL estimates were graded moderate quality because of inconsistency, and apoB high quality. The 2024 analysis (29 trials, 2,769 people) found total cholesterol down 0.28 mmol/L and LDL down 0.35 mmol/L, with no substantial effect on HDL or triglycerides. A 2009 analysis (21 trials) found total cholesterol down 0.375 mmol/L and LDL down 0.278 mmol/L, and the 2000 analysis found LDL 7% lower and total cholesterol 4% lower at 10.2 g a day on a low-fat diet.

A 2025 dose-response analysis (41 trials, 2,049 people) found LDL down 8.55 mg/dL and total cholesterol down 9.05 mg/dL, again with no significant HDL or triglyceride change.

An 8-week double-blind trial in 118 adults with primary hypercholesterolaemia gave 5.1 g of psyllium twice a day. LDL fell 7.2% on a high-fat diet and 6.4% on a low-fat diet, with no significant change in the placebo group, and the authors called the effect modest.

A crossover trial of 68 hyperlipidaemic adults tested foods supplying the FDA-approved dose of soluble fibre, from either psyllium or beta-glucan. The high-fibre diet lowered total cholesterol by 2.1% (P = 0.003) and estimated Framingham risk by 4.2%. Because the fibres were mixed, it does not isolate psyllium.

In a 12-week blinded trial of 68 patients, simvastatin 10 mg plus 15 g of psyllium lowered LDL by 63 mg/dL after 8 weeks, versus 55 mg/dL for simvastatin 10 mg plus placebo (P = .03). That matched simvastatin 20 mg alone. A meta-analysis of three trials (4 to 12 weeks) agreed: the extra reduction was equivalent to doubling the statin dose. The sample is small and the follow-up short, but it supports psyllium as an option for people who cannot tolerate a higher statin dose, discussed with their prescriber.

Heterogeneity is the main caveat: between trials, I2 reached 88% for LDL in the 2025 analysis, and the 2018 analysis downgraded certainty for inconsistency. Children are the clearest conflict. An 8-week trial in 51 young people (6 to 19 years) found LDL down 10.7% (P = 0.01) at 7 g a day, while a crossover trial in 20 children on a cholesterol-lowering diet found no extra lowering at 6 g a day.

In people with diabetes, a meta-analysis of 8 trials (395 people) found LDL down 8.96 mg/dL and triglycerides down 19.18 mg/dL, with very high heterogeneity. No trial reported here measured heart attacks, strokes or deaths. A 2024 clinician review put psyllium among supplements with modest LDL reductions while noting quality concerns across the supplement field and a limited role for supplements in clinical practice.

Across the trials psyllium was well tolerated. The 2000 meta-analysis summarised safety from 19 clinical studies of 6 weeks to 6 months and judged it safe alongside a low-fat diet. In the statin trial all treatments were well tolerated, and the children's trial reported no serious adverse effects. The 4-serving food trial found no significant difference in gastrointestinal symptoms between diets.

The real hazards are practical. MedlinePlus says the powder and granules must be mixed with at least 8 ounces (240 mL) of liquid, and that people with difficulty swallowing or intestinal blockage should tell their doctor first. It also advises against inhaling the powder, which can cause allergic reactions, and says to seek help straight away for difficulty breathing, stomach pain, difficulty swallowing, vomiting or rash.

Psyllium is a bulking agent and can interact with the timing of other medicines. MedlinePlus advises not taking digoxin, salicylates such as aspirin, or nitrofurantoin within 3 hours of psyllium. A small single-dose study of 8 volunteers found levothyroxine absorption of 80% with psyllium versus 89% alone, and the authors judged malabsorption unlikely to be detectable. That is one small study, so people on thyroid replacement should still ask their prescriber about spacing.